Quick Answer
ADMA BIOLOGICS, INC. reported Total Revenue of $510.17 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed an increase of +19.6% in Total Revenue from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $0.00 | Q3 2011: $0.00 | Q1 2012: $4.4 thousand | Q2 2012: $230.1 thousand | Q3 2012: $360.3 thousand | Q1 2013: $792.9 thousand | Q2 2013: $743.3 thousand | Q3 2013: $1.11 million | Q1 2014: $1.56 million | Q2 2014: $1.50 million | Q3 2014: $1.37 million | Q1 2015: $1.50 million | Q2 2015: $1.31 million | Q3 2015: $1.85 million | Q1 2016: $2.12 million | Q2 2016: $2.27 million | Q3 2016: $2.94 million | Q1 2017: $2.63 million | Q2 2017: $3.40 million | Q3 2017: $4.73 million | Q1 2018: $4.04 million | Q2 2018: $4.66 million | Q3 2018: $4.23 million | Q4 2018: $4.06 million | Q1 2019: $3.53 million | Q2 2019: $6.56 million | Q3 2019: $7.22 million | Q1 2020: $10.20 million | Q2 2020: $7.79 million | Q2 2020: $7.79 million | Q3 2020: $10.28 million | Q3 2020: $10.28 million | Q1 2021: $16.05 million | Q1 2021: $16.05 million | Q2 2021: $17.83 million | Q3 2021: $20.68 million | Q1 2022: $29.10 million | Q2 2022: $33.91 million | Q3 2022: $41.09 million | Q1 2023: $56.91 million | Q2 2023: $60.12 million | Q3 2023: $67.28 million | Q1 2024: $81.88 million | Q2 2024: $107.19 million | Q3 2024: $119.84 million | Q1 2025: $114.80 million | Q2 2025: $121.98 million | Q3 2025: $134.22 million.
- Over the full 16 years of available data (2011 to 2025), ADMA BIOLOGICS, INC.'s Total Revenue has grown by 66,936.1%.
- Historical annual values: Fiscal year 2025: $510.17 million | Fiscal year 2024: $426.45 million | Fiscal year 2023: $258.22 million | Fiscal year 2022: $154.08 million | Fiscal year 2021: $80.94 million | Fiscal year 2020: $42.22 million | Fiscal year 2020: $42.22 million | Fiscal year 2019: $29.35 million | Fiscal year 2018: $16.99 million | Fiscal year 2017: $22.76 million | Fiscal year 2016: $10.66 million | Fiscal year 2015: $7.18 million | Fiscal year 2014: $5.92 million | Fiscal year 2013: $3.07 million | Fiscal year 2012: $1.12 million | Fiscal year 2011: $761.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: